1981. |
1982. |
1983. |
1984. |
1985. Relevance of cold-rolling technology for the texture and anisotropy of EN AW-8011A aluminum alloysJakob Kraner, Kyung Il Kim, Bonghwan Kim, Shae K. Kim, Irena Paulin, 2023, original scientific article Keywords: aluminium alloys, cold rolling, SEM-EBSD, textures, anisotropy Published in DiRROS: 08.03.2024; Views: 424; Downloads: 225 Full text (2,04 MB) This document has many files! More... |
1986. |
1987. Effect of steel’s thermal condition on the transformation temperatures of two hot-work tool steels with increased thermal conductivity : Tilen Balaško, Jaka Burja, Jožef MedvedTilen Balaško, Jaka Burja, Jože Medved, 2023, original scientific article Keywords: thermal analysis, hot-work tool steels, differential scanning calorimetry, heat treatment Published in DiRROS: 08.03.2024; Views: 437; Downloads: 186 Full text (3,08 MB) This document has many files! More... |
1988. |
1989. |
1990. Cisplatin-induced non-convulsive posterior reversible encephalopathy syndrome in a 41-year-old woman with metastatic malignant melanomaJanja Ocvirk, Marko Boc, Martina Reberšek, Tanja Roš-Opaškar, 2009, original scientific article Abstract: Background. Cisplatin, a widely used antineoplastic agent usually induces peripheral neuropathy, but can rarely also complicate with encephalopathy, with or without seizures. Case report. We report a case of a young patient with metastatic malignant melanoma with signs and symptoms of cisplatin-induced non-convulsive posterior reversible encephalopaty syndrome. Within the days shortly after the first cycle of cisplatin based chemotherapy the patient suffered from nausea, vomitus, headache, severe pain at the site of sub-cutaneous metastases and confusion. She later experienced somnolence, cortical blindness and aphasia, but without epileptic seizures. Conclusions. Cisplatin is an effective chemotherapeutic drug but also very toxic one and physicians using it must also be aware of possible encephalopathy. Published in DiRROS: 08.03.2024; Views: 454; Downloads: 114 Full text (343,74 KB) |